Hologen AI has pledged up to $430 million through a strategic partnership to sup...
After almost a decade of contending with bankruptcy filings and opioid settlemen...
Roche has committed to an initial payment of $1.65 billion to enhance its growin...
Health Canada has granted approval for Biogen’s Skyclarys to treat Friedreich’s ...
The use of AI in drug discovery and development has been recognised, explored, a...
AstraZeneca has entered an exclusive licence agreement with Alteogen involving t...
Experts at the 2025 Clinical Trial Supply New England conference will discuss st...
The two simultaneous Incyte trials in HS saw more than 40% of patients on povorc...
Latigo has secured $150m in a Series funding round, which will be used to furthe...
While China has become a key country for global clinical trials, navigating regu...
GSK’s shingles vaccine Shingrix passed $1bn in sales last year as Curevo aims to...
Arbor Biotechnologies has closed $73.9m for its gene editing therapeutic pipelin...
Opko Health and Entera Bio have announced a partnership and licence agreement to...
The United States Environmental Protection Agency (EPA) has faced significant sc...
HOUSTON – March 18, 2025, marks a pivotal moment in the fight against prostate c...
In a groundbreaking advancement for chemical analysis, researchers at Florida St...
